Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$18.2 million.

  • Agilon Health's Cash from Operations fell 13567.44% to -$18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.8 million, marking a year-over-year increase of 4916.82%. This contributed to the annual value of -$57.8 million for FY2024, which is 6301.06% up from last year.
  • Latest data reveals that Agilon Health reported Cash from Operations of -$18.2 million as of Q3 2025, which was down 13567.44% from -$35.1 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Cash from Operations ranged from a high of $16.4 million in Q4 2024 and a low of -$61.2 million during Q4 2023
  • Over the past 5 years, Agilon Health's median Cash from Operations value was -$32.0 million (recorded in 2025), while the average stood at -$30.4 million.
  • As far as peak fluctuations go, Agilon Health's Cash from Operations crashed by 59180.2% in 2023, and later surged by 12684.33% in 2024.
  • Agilon Health's Cash from Operations (Quarter) stood at -$48.9 million in 2021, then fell by 2.17% to -$50.0 million in 2022, then fell by 22.43% to -$61.2 million in 2023, then soared by 126.84% to $16.4 million in 2024, then crashed by 210.57% to -$18.2 million in 2025.
  • Its last three reported values are -$18.2 million in Q3 2025, -$35.1 million for Q2 2025, and -$32.0 million during Q1 2025.